Diagnosis and management of peripartum cardiomyopathy

Blauwet, Lori A.; Cooper, Leslie T.
December 2011
Heart;Dec2011, Vol. 97 Issue 23, p1970
Academic Journal
The article discusses the challenges involved in the diagnosis of Peripartum cardiomyopathy (PPCM) in women as symptoms differ during pregnancy and postpartum due to normal physiological changes. The PPCM is a rare idiopathic form of heart failure. Several hypotheses have been proposed to find out the accurate cause and mechanism of PPCM. Some of the common symptoms in PPCM patients include dyspnoea, peripheral oedema, and fatigue. INSETS: Proposed aetiologies and pathophysiological;Symptoms of PPCM;Signs of PPCM;PPCM is a diagnosis of exclusion


Related Articles

  • The Treatment of Heart Failure-Related Symptoms with Ivabradine in a Case with Peripartum Cardiomyopathy. Demir, Serafettin; Tufenk, Mucahit; Karakaya, Zeynep; Akilli, Rabia; Kanadas, Mehmet // International Cardiovascular Research Journal;2013, Vol. 7 Issue 1, p33 

    Peripartum cardiomyopathy is a form of dilated cardiomyopathy that is defined as deterioration in cardiac function presenting typically between the last month of pregnancy and up to five months postpartum. As with other forms of dilated cardiomyopathy, PPCM involves systolic dysfunction of the...

  • Alcoholic Cardiomyopathy In A 39 Year Old Female: A Case Report. D. I., Uchenna; J. I., Anyalechi; D. E., Jesuorobo // Internet Journal of Cardiology;2011, Vol. 10 Issue 1, p1 

    Background: Alcoholic cardiomyopathy is a dilated cardiomyopathy, caused by long standing chronic ingestion of alcohol. It is very similar to idiopathic dilated cardiomyopathy (DCM). However, total cessation of alcohol is strongly associated with improvement of symptoms and even reversal of the...

  • From failure to triumph. Awe, Olatunji // Cortlandt Forum;06/25/99, Vol. 12 Issue 6, p75 

    Discusses the case of a 45-year-old male Latino-American patient who presented to the emergency department with progressively worsening dyspnea of 20 years' duration associated with orthopnea, paroxysmal nocturnal dyspnea, palpitations, and decreasing exercise tolerance. Symptoms of...

  • Measuring breathlessness among patients with heart failure. Linden, Belinda // British Journal of Cardiac Nursing;Mar2010, Vol. 5 Issue 3, p149 

    The article reports on the findings of a study stating that the measuring of breathlessness during exercise or other activities allows researchers to acquire a deeper understanding of the impact of breathlessness on the ability of patients with heart failure to cope and to monitor any...

  • Measurement of postpartum blood loss. Prata, Ndola; Gerdts, Caitlin // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/6/2010, Vol. 340 Issue 7741, p274 

    The authors analyze a study which assessed whether using a transparent plastic collector bag to measure postpartum blood loss after vaginal delivery reduced the incidence of severe postpartum haemorrhage. They reveal that the study was conducted in hospitals in 13 European countries. They note...

  • Tropical endomyocardial fibrosis in India: a vanishing disease! Vijayaraghavan, G.; Sivasankaran, S. // Indian Journal of Medical Research;Nov2012, Vol. 136 Issue 5, p729 

    Tropical endomyocardial fibrosis in India was a common medical problem in the coastal districts of south India, especially the Kerala State. The clinical and autopsy studies have shown left and right ventricular apical fibrosis, with varying degree of atrioventricular valve regurgitation. Left...

  • Impact of new electrocardiographic criteria in arrhythmogenic cardiomyopathy. Hauer, Richard N. W.; Cox, Moniek G. P. J.; Groeneweg, Judith A. // Frontiers in Physiology;Sep2012, Vol. 3, p1 

    Arrhythmogenic cardiomyopathy (AC) has originally been described as a disorder characterized by fibrofatty replacement of the myocardium, primarily of the right ventricle (RV), and ventricular tachyarrhythmias, sudden death, and at a late stage progressive heart failure. Arrhythmogenic right...

  • Report of methamphetamine use and cardiomyopathy in three patients. Sadeghi, Roxana; Agin, Khosro; Taherkhani, Maryam; Najm-Afshar, Leila; S Nelson, Lewis; Abdollahi, Mohammad; Shadnia, Shahin // DARU;2012, Vol. 20, p1 

    Background: Methamphetamine (meth) is a stimulant used illegally around the world, including in Iran. Cardiomyopathy and cardiac failure may occur following chronic meth use and may cause the patients referred to the emergency department. Case reports: A 28-year old man and two women, ages 29...

  • Cyclophosphamide/epirubicin/paclitaxel.  // Reactions Weekly;Aug2015, Vol. 1563 Issue 1, p71 

    The article presents a case study of a 70-year-old woman who was diagnosed with reversible cardiomyopathy and congestive heart failure following a chemotherapy with cyclophosphamide, epirubicin and paclitaxel for breast cancer.


Read the Article


Sign out of this library

Other Topics